Edition:
United Kingdom

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.77USD
14 Dec 2018
Change (% chg)

$0.07 (+4.12%)
Prev Close
$1.70
Open
$1.71
Day's High
$1.77
Day's Low
$1.71
Volume
8,345
Avg. Vol
10,654
52-wk High
$4.85
52-wk Low
$1.63

Chart for

About

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal... (more)

Overall

Beta: -8.40
Market Cap(Mil.): $71.13
Shares Outstanding(Mil.): 0.12
Dividend: --
Yield (%): --

Financials

  AKTX.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.84 -- --
ROI: -68.01 9.01 14.96
ROE: -68.13 10.15 16.52

Earnings vs. Estimates